LMR Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History

LMR Partners’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,948	Closed	-$546K	–	1532
2025 Q3	$546K	Hold	1,948	–	–	﹤0.01%	1076
2025 Q2	$470K	Buy	+1,948	New	+$460K	﹤0.01%	962
2024 Q1	–	Sell	-2,506	Closed	-$809K	–	1160
2023 Q4	$809K	Buy	+2,506	New	+$785K	0.01%	602
2021 Q1	–	Sell	-712	Closed	-$415K	–	960
2020 Q4	$415K	Buy	+712	New	+$405K	0.01%	361
2019 Q4	–	Sell	-12,460	Closed	-$4.15M	–	411
2019 Q3	$4.15M	Buy	12,460 +4,008	+47%	+$1.31M	0.21%	74
2019 Q2	$2.64M	Buy	8,452 +6	+0.1%	+$1.8K	0.1%	108
2019 Q1	$2.58M	Buy	+8,446	New	+$2.28M	0.13%	107
2018 Q4	–	Sell	-3,445	Closed	-$1.08M	–	343
2018 Q3	$1.08M	Buy	+3,445	New	+$1.07M	0.07%	131

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LMR Partners's BIO Position: Q4 2025 in Review

LMR Partners sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2025, closing a stake of 1,948 shares — an estimated $546K sold.

LMR Partners first reported a position in BIO in Q3 2018 and held it in 8 quarters. The position peaked at $4.15M in Q3 2019. 399 funds tracked by Wall St. Rank hold BIO as of Q4 2025.

LMR Partners reported no remaining Bio-Rad Laboratories Class A position as of Q4 2025 after selling out during the quarter.
LMR Partners sold 1,948 Bio-Rad Laboratories Class A shares in Q4 2025, an estimated $546K.
LMR Partners first reported a position in Bio-Rad Laboratories Class A in Q3 2018 and held it in 8 quarters.
LMR Partners's Bio-Rad Laboratories Class A position peaked at $4.15M in Q3 2019.
399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2025.

Based on LMR Partners's 13F filing for Q4 2025, filed 17 Feb 2026.